Marketplace Morning Report How new ways to prevent RSV are savings lives and money
May 26, 2025
This discussion reveals groundbreaking advances in RSV prevention, focusing on a maternal vaccine and antibodies for newborns, which significantly reduce hospitalizations. The economic impact is clear: fewer hospital visits mean savings for families and taxpayers alike. Additionally, the conversation addresses rising financial distress among older adults, drawing parallels to past economic crises. Finally, listeners get practical strategies to tackle credit card debt before retirement, ensuring a more secure financial future.
AI Snips
Chapters
Transcript
Episode notes
New RSV Prevention Lowers Hospitalizations
- New RSV prevention methods drastically reduced infant hospitalizations last winter.
- This lowers healthcare costs and improves family health outcomes significantly.
Medicaid Bears RSV Costs
- Medicaid pays for 61% of RSV infant hospitalizations, costing $350 million annually.
- Increasing RSV prevention coverage could greatly reduce this financial burden on taxpayers.
RSV Has Long-Term Effects
- RSV severe infection in infants raises their future asthma risk.
- Parents also miss work due to infant illness, adding indirect societal costs.